Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Net Income (2016 - 2026)

Sunshine Biopharma filings provide 12 years of Net Income readings, the most recent being $5.1 million for Q4 2025.

  • On a quarterly basis, Net Income rose 16.86% to $5.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 9.43% decrease, with the full-year FY2025 number at $1.2 million, down 9.43% from a year prior.
  • Net Income hit $5.1 million in Q4 2025 for Sunshine Biopharma, up from -$883820.0 in the prior quarter.
  • In the past five years, Net Income ranged from a high of $5.1 million in Q4 2025 to a low of -$23.5 million in Q4 2022.
  • Median Net Income over the past 5 years was -$1.2 million (2022), compared with a mean of -$2.1 million.
  • Biggest five-year swings in Net Income: plummeted 3624.47% in 2022 and later skyrocketed 446.59% in 2024.
  • Sunshine Biopharma's Net Income stood at $667116.0 in 2021, then plummeted by 3624.47% to -$23.5 million in 2022, then surged by 94.68% to -$1.3 million in 2023, then skyrocketed by 446.59% to $4.3 million in 2024, then rose by 16.86% to $5.1 million in 2025.
  • The last three reported values for Net Income were $5.1 million (Q4 2025), -$883820.0 (Q3 2025), and -$1.8 million (Q2 2025) per Business Quant data.